https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/dividends-per-share https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/financing-receivable-allowance-for-credit-losses https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/insider-transactions-stock-options/sales https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/property-plant-and-equipment-fair-value-disclosure https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/severance-costs https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/shares-issued-for-options-exercised https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/utb-income-tax-penalties-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/utb-interest-on-income-taxes-expense https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation https://stock.noler.com/us/stock/satsuma-pharmaceuticals-inc/weighted-average-number-of-shares-issued-basic